Explore more publications!

Press Releases

VideoCX.io Launches Dedicated Video Ident Platform for German Financial Institutions
Italy Reviews Turkey’s Unmanned Surface Vehicles

Italy Reviews Turkey’s Unmanned Surface Vehicles

EU Calls to Strengthen Defense as Security Threats Rise

EU Calls to Strengthen Defense as Security Threats Rise

Studio Panama Italia: Legal Framework for the Panama-Italy Treaty Residency Route
Exception Management in the Banking Operations Sector: Industry Analysis Report 2026 Major Trends, Drivers and Forecasts
Governor Shapiro Secures Historic $3.5 Billion Investment from Lilly to Build New, State-of-the-Art Pharmaceutical Manufacturing Facility in Lehigh County, Creating 850 New Jobs

Governor Shapiro Secures Historic $3.5 Billion Investment from Lilly to Build New, State-of-the-Art Pharmaceutical Manufacturing Facility in Lehigh County, Creating 850 New Jobs

Governor Shapiro Secures Historic $3.5 Billion Investment from Lilly to Build New, State-of-the-Art Pharmaceutical Manufacturing Facility in Lehigh County, Creating 850 New Jobs

Governor Shapiro Secures Historic $3.5 Billion Investment from Lilly to Build New, State-of-the-Art Pharmaceutical Manufacturing Facility in Lehigh County, Creating 850 New Jobs

ZBH Alert: Hagens Berman Investigates Zimmer Biomet (ZBH) Over Alleged Emerging Market Failures and “Inconsistent” Execution
U.S. Law Enforcement Assists Bulgarian Law Enforcement in Taking Down Three of the Largest Piracy Sites in The European Union

U.S. Law Enforcement Assists Bulgarian Law Enforcement in Taking Down Three of the Largest Piracy Sites in The European Union

Russian Sandworm group attacks energy company in Poland with DynoWiper, ESET Research discovers
Merz Refutes Zelensky’s Demand for 2027 Accession Date to EU

Merz Refutes Zelensky’s Demand for 2027 Accession Date to EU

Adagio Medical to Present at the Small Cap Growth Virtual Investor Conference February 5th
Chiesi Global Rare Diseases and Protalix BioTherapeutics Receive Positive CHMP Opinion for an Additional Dosing Regimen of Every Four Weeks for Elfabrio® (pegunigalsidase alfa) in the EU
Chiesi Global Rare Diseases and Protalix BioTherapeutics Receive Positive CHMP Opinion for an Additional Dosing Regimen of 2mg/kg Body Weight Every-Four-Weeks for Elfabrio® (pegunigalsidase alfa) ▼ in the EU
Actelis Networks Receives Significant Expansion Order from Major European Natural Gas Operator, Continuing Critical Infrastructure Modernization
Gentex Reports Fourth Quarter And Year End 2025 Financial Results
Press Release: Sanofi’s Rezurock recommended for EU approval by the CHMP to treat chronic graft-vs-host disease
Saratoga Investment Corp. Prices Public Offering of   $100 Million 7.50% Notes Due 2031
Regeneron Reports Fourth Quarter and Full Year 2025 Financial and Operating Results
Althera and Bruno Farmaceutici Sign Strategic Licensing Agreement to Bring Advanced Type 2 Diabetes Therapy to Italy

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions